Which statement best differentiates irreversible enzyme inhibitors from reversible inhibitors in pharmacology?

Which statement best differentiates irreversible enzyme inhibitors from reversible inhibitors in pharmacology?

• A. Irreversible inhibitors form covalent bonds and permanently inactivate enzymes; reversible inhibitors bind non-covalently and can dissociate.
• B. Irreversible inhibitors are always more potent than reversible ones.
• C. Reversible inhibitors require covalent modification to function.
• D. Irreversible inhibitors only affect prokaryotic enzymes.

Answer: (A)

In pharmacology, the key distinction is how the inhibitor interacts with the enzyme and what happens when the inhibitor is removed. Irreversible inhibitors form covalent bonds with the enzyme, permanently inactivating it. Because of this covalent modification, the enzyme cannot regain activity, and recovery only occurs when new enzyme molecules are synthesized by the cell. Reversible inhibitors, on the other hand, bind through non-covalent interactions and can dissociate from the enzyme. Their effects disappear as the inhibitor concentration falls or the inhibitor is removed, allowing the enzyme to resume activity. That makes the chosen statement the best because it directly captures this fundamental difference: covalent bonding with permanent inactivation versus non-covalent binding with the ability to dissociate. The other ideas aren’t reliable generalizations: potency isn’t fixed as higher for irreversible inhibitors—it's highly context-dependent on binding strength; irreversible inhibitors can and do affect enzymes in both prokaryotes and eukaryotes; and reversible inhibitors do not require covalent modification.

In pharmacology, the key distinction is how the inhibitor interacts with the enzyme and what happens when the inhibitor is removed. Irreversible inhibitors form covalent bonds with the enzyme, permanently inactivating it. Because of this covalent modification, the enzyme cannot regain activity, and recovery only occurs when new enzyme molecules are synthesized by the cell. Reversible inhibitors, on the other hand, bind through non-covalent interactions and can dissociate from the enzyme. Their effects disappear as the inhibitor concentration falls or the inhibitor is removed, allowing the enzyme to resume activity.

That makes the chosen statement the best because it directly captures this fundamental difference: covalent bonding with permanent inactivation versus non-covalent binding with the ability to dissociate. The other ideas aren’t reliable generalizations: potency isn’t fixed as higher for irreversible inhibitors—it's highly context-dependent on binding strength; irreversible inhibitors can and do affect enzymes in both prokaryotes and eukaryotes; and reversible inhibitors do not require covalent modification.